ID: ALA5076607

Max Phase: Preclinical

Molecular Formula: C42H41FN10O8

Molecular Weight: 832.85

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C1CCC(N2C(=O)c3cccc(NCCOCCn4cc(CCC(=O)N5CCN(C(=O)c6cc(Cc7n[nH]c(=O)c8ccccc78)ccc6F)CC5)nn4)c3C2=O)C(=O)N1

Standard InChI:  InChI=1S/C42H41FN10O8/c43-31-10-8-25(23-33-27-4-1-2-5-28(27)38(56)48-47-33)22-30(31)40(58)51-17-15-50(16-18-51)36(55)13-9-26-24-52(49-46-26)19-21-61-20-14-44-32-7-3-6-29-37(32)42(60)53(41(29)59)34-11-12-35(54)45-39(34)57/h1-8,10,22,24,34,44H,9,11-21,23H2,(H,48,56)(H,45,54,57)

Standard InChI Key:  GJAZJINCGLPCSE-UHFFFAOYSA-N

Associated Targets(Human)

Protein cereblon/Epidermal growth factor receptor 191 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cereblon/PARP1 186 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 832.85Molecular Weight (Monoisotopic): 832.3093AlogP: 1.69#Rotatable Bonds: 14
Polar Surface Area: 221.89Molecular Species: NEUTRALHBA: 13HBD: 3
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.95CX Basic pKa: 1.49CX LogP: 1.30CX LogD: 1.30
Aromatic Rings: 5Heavy Atoms: 61QED Weighted: 0.11Np Likeness Score: -1.44

References

1. Zheng M, Huo J, Gu X, Wang Y, Wu C, Zhang Q, Wang W, Liu Y, Liu Y, Zhou X, Chen L, Zhou Y, Li H..  (2021)  Rational Design and Synthesis of Novel Dual PROTACs for Simultaneous Degradation of EGFR and PARP.,  64  (11.0): [PMID:34038131] [10.1021/acs.jmedchem.1c00649]

Source